Abstract
In this study, we present a 64-year-old African American woman with hypopigmented macular areas on her face, hands, and trunk. The lesions first appeared on her hands in early summer of 2021, three months after receiving the first dose of the Moderna COVID-19 vaccine, eventually spreading to her face, abdomen, and back. The patient has a history of Systemic Erythematous Lupus (SLE), currently on Plaquenil, with autoimmune testing positive for ANA and anti-SSB. She reported no personal or family history of vitiligo. She was first examined by Rheumatology and was prescribed a trial of CellCept but discontinued using it due to blistering on her face. She was then referred to a Dermatology clinic. On examination, there were depigmented white macules and patches consistent with vitiligo. The diagnosis was confirmed upon dermatological and woods lamp examination. She was prescribed a topical calcineurin inhibitor and was instructed to return to the clinic for follow-up.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
